Fintel reports that on May 31, 2024, Piper Sandler initiated coverage of Elevation Oncology (NasdaqGS:ELEV) with a Overweight recommendation. As of May 22, 2024, the average one-year price target for ...
Fintel reports that on January 3, 2025, William Blair initiated coverage of Elevation Oncology (NasdaqGS:ELEV) with a Outperform recommendation. As of December 23, 2024, the average one-year price ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback